157 filings
Page 3 of 8
8-K
xmww icu15pfcr8
17 May 22
Departure of Directors or Certain Officers
9:00am
8-K
g72freju4ie2jdi3n8m
10 May 22
Avinger Reports First Quarter 2022 Results
4:06pm
8-K
m3c6yqe86
3 May 22
Departure of Directors or Certain Officers
5:00pm
8-K
tkpkmj
1 Apr 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:05pm
8-K
1k8m765
29 Mar 22
Regulation FD Disclosure
5:09pm
8-K
ar2ju9
25 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
el26ediwkdkivdik4nyc
22 Mar 22
Avinger Reports Fourth Quarter and Year End 2021 Results
4:05pm
8-K
55v73c3j23m8rxfz8 oc
14 Mar 22
Material Modifications to Rights of Security Holders
8:30am
8-K
jua f650j336e
11 Mar 22
Submission of Matters to a Vote of Security Holders
4:24pm
8-K
lytydx1arbxx
18 Jan 22
Avinger, Inc. Announces Closing of $7.6 Million Registered Direct Offering
4:05pm
8-K
7mtb leh37
12 Jan 22
Avinger Announces $7.6 Million Registered Direct Offering
4:46pm
8-K
39fp5ioi
11 Jan 22
Avinger Announces 510(k) Clearance for Lightbox 3
8:45am
8-K
uteup3 4wzzy
27 Dec 21
Unregistered Sales of Equity Securities
4:05pm
8-K
1h841c
20 Dec 21
Submission of Matters to a Vote of Security Holders
5:22pm
8-K
05wbcsy3zx jt
17 Nov 21
Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis
4:05pm
8-K
5jexql9l
12 Nov 21
Avinger Reports Third Quarter 2021 Financial Results
6:33am
8-K
2d50mv7ojqfh7tt
29 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
7339sglds 5beh9r36p
24 Sep 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
svn18pcuyk 74npu
10 Aug 21
Avinger Reports Second Quarter 2021 Financial Results
4:10pm
8-K
k2vvsf6qhedt 63jhd
9 Aug 21
Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console
9:00am